within Pharmacolibrary.Drugs.ATC.A;

model A11GB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A11GB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combination drug of ascorbic acid (vitamin C) and calcium, aimed at supplementing vitamin C and calcium levels. Used in the prevention and treatment of vitamin C and calcium deficiencies. The drug is an over-the-counter supplement, widely used today, but not indicated for specific disease treatment.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals due to lack of published clinical PK studies for the fixed combination. Values based on known pharmacokinetics of individual components (ascorbic acid and calcium salts).</p><h4>References</h4><ol><li><p>Lee, JK, et al., &amp; Myung, CS (2018). Alleviation of ascorbic acid-induced gastric high acidity by calcium ascorbate . <i>The Korean journal of physiology &amp; pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology</i> 22(1) 35–42. DOI:<a href=&quot;https://doi.org/10.4196/kjpp.2018.22.1.35&quot;>10.4196/kjpp.2018.22.1.35</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29302210/&quot;>https://pubmed.ncbi.nlm.nih.gov/29302210</a></p></li><li><p>Elmore, AR (2005). Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. <i>International journal of toxicology</i> 24 Suppl 2 51–111. DOI:<a href=&quot;https://doi.org/10.1080/10915810590953851&quot;>10.1080/10915810590953851</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16154915/&quot;>https://pubmed.ncbi.nlm.nih.gov/16154915</a></p></li><li><p>Joseph, A, et al., &amp; Im, K (2021). Surface-engineered liposomal particles of calcium ascorbate with fenugreek galactomannan enhanced the oral bioavailability of ascorbic acid: a randomized, double-blinded, 3-sequence, crossover study. <i>RSC advances</i> 11(60) 38161–38171. DOI:<a href=&quot;https://doi.org/10.1039/d1ra06483e&quot;>10.1039/d1ra06483e</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35498071/&quot;>https://pubmed.ncbi.nlm.nih.gov/35498071</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A11GB01;
